Literature DB >> 30366922

The von Willebrand factor Tyr2561 allele is a gain-of-function variant and a risk factor for early myocardial infarction.

Reinhard Schneppenheim1, Natalie Hellermann2, Maria A Brehm1, Ulrike Klemm1, Tobias Obser1, Volker Huck3,4, Stefan W Schneider3, Cécile V Denis5, Alexander Tischer6, Matthew Auton6, Winfried März7,8,9, Emma-Ruoqi Xu10, Matthias Wilmanns10,11, Rainer B Zotz12.   

Abstract

The frequent von Willebrand factor (VWF) variant p.Phe2561Tyr is located within the C4 domain, which also harbors the platelet GPIIb/IIIa-binding RGD sequence. To investigate its potential effect on hemostasis, we genotyped 865 patients with coronary artery disease (CAD), 915 with myocardial infarction (MI), and 417 control patients (Ludwigshafen Risk and Cardiovascular Health Study) and performed functional studies of this variant. A univariate analysis of male and female carriers of the Tyr2561 allele aged 55 years or younger revealed an elevated risk for repeated MI (odds ratio, 2.53; 95% confidence interval [CI], 1.07-5.98). The odds ratio was even higher in females aged 55 years or younger, at a value of 5.93 (95% CI, 1.12-31.24). Cone and plate aggregometry showed that compared with Phe2561, Tyr2561 was associated with increased platelet aggregate size both in probands' blood and with the recombinant variants. Microfluidic assays revealed that the critical shear rate for inducing aggregate formation was decreased to 50% by Tyr2561 compared with Phe2561. Differences in C-domain circular dichroism spectra resulting from Tyr2561 suggest an increased shear sensitivity of VWF as a result of altered association of the C domains that disrupts the normal dimer interface. In summary, our data emphasize the functional effect of the VWF C4 domain for VWF-mediated platelet aggregation in a shear-dependent manner and provide the first evidence that a functional variant of VWF plays a role in arterial thromboembolism.
© 2019 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30366922      PMCID: PMC6347094          DOI: 10.1182/blood-2018-04-843425

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   25.476


  40 in total

1.  Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis.

Authors:  A Di Castelnuovo; G de Gaetano; M B Donati; L Iacoviello
Journal:  Thromb Haemost       Date:  2001-04       Impact factor: 5.249

2.  HUMAN EXPERIMENTATION. CODE OF ETHICS OF THE WORLD MEDICAL ASSOCIATION. DECLARATION OF HELSINKI.

Authors:  P P RICKHAM
Journal:  Br Med J       Date:  1964-07-18

3.  Polymorphism of platelet membrane glycoprotein IIIa: human platelet antigen 1b (HPA-1b/PlA2) is an inherited risk factor for premature myocardial infarction in coronary artery disease.

Authors:  R B Zotz; B R Winkelmann; M Nauck; G Giers; B Maruhn-Debowski; W März; R E Scharf
Journal:  Thromb Haemost       Date:  1998-04       Impact factor: 5.249

Review 4.  Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review.

Authors:  M C van Schie; J E van Loon; M P M de Maat; F W G Leebeek
Journal:  J Thromb Haemost       Date:  2011-05       Impact factor: 5.824

5.  ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men.

Authors:  Chan K N K Chion; Carine J M Doggen; James T B Crawley; David A Lane; Frits R Rosendaal
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  Testing of platelet deposition on polystyrene surface under flow conditions by the cone and plate(let) analyzer: role of platelet activation, fibrinogen and von Willebrand factor.

Authors:  B Shenkman; N Savion; R Dardik; I Tamarin; D Varon
Journal:  Thromb Res       Date:  2000-08-15       Impact factor: 3.944

Review 7.  The various states of von Willebrand factor and their function in physiology and pathophysiology.

Authors:  Volker Huck; Matthias F Schneider; Christian Gorzelanny; Stefan W Schneider
Journal:  Thromb Haemost       Date:  2014-02-27       Impact factor: 5.249

8.  A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

Authors:  E J Weiss; P F Bray; M Tayback; S P Schulman; T S Kickler; L C Becker; J L Weiss; G Gerstenblith; P J Goldschmidt-Clermont
Journal:  N Engl J Med       Date:  1996-04-25       Impact factor: 91.245

9.  Reduced prevalence of arterial thrombosis in von Willebrand disease.

Authors:  Y V Sanders; J Eikenboom; E M de Wee; J G van der Bom; M H Cnossen; M E L Degenaar-Dujardin; K Fijnvandraat; P W Kamphuisen; B A P Laros-van Gorkom; K Meijer; E P Mauser-Bunschoten; F W G Leebeek
Journal:  J Thromb Haemost       Date:  2013-05       Impact factor: 5.824

10.  Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Authors:  Emma-Ruoqi Xu; Sören von Bülow; Po-Chia Chen; Peter J Lenting; Katra Kolšek; Camilo Aponte-Santamaría; Bernd Simon; Jaelle Foot; Tobias Obser; Reinhard Schneppenheim; Frauke Gräter; Cécile V Denis; Matthias Wilmanns; Janosch Hennig
Journal:  Blood       Date:  2018-10-10       Impact factor: 22.113

View more
  6 in total

1.  Structure and dynamics of the platelet integrin-binding C4 domain of von Willebrand factor.

Authors:  Emma-Ruoqi Xu; Sören von Bülow; Po-Chia Chen; Peter J Lenting; Katra Kolšek; Camilo Aponte-Santamaría; Bernd Simon; Jaelle Foot; Tobias Obser; Reinhard Schneppenheim; Frauke Gräter; Cécile V Denis; Matthias Wilmanns; Janosch Hennig
Journal:  Blood       Date:  2018-10-10       Impact factor: 22.113

2.  Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.

Authors:  Sara Lindström; Lu Wang; Erin N Smith; William Gordon; Astrid van Hylckama Vlieg; Mariza de Andrade; Jennifer A Brody; Jack W Pattee; Jeffrey Haessler; Ben M Brumpton; Daniel I Chasman; Pierre Suchon; Ming-Huei Chen; Constance Turman; Marine Germain; Kerri L Wiggins; James MacDonald; Sigrid K Braekkan; Sebastian M Armasu; Nathan Pankratz; Rebecca D Jackson; Jonas B Nielsen; Franco Giulianini; Marja K Puurunen; Manal Ibrahim; Susan R Heckbert; Scott M Damrauer; Pradeep Natarajan; Derek Klarin; Paul S de Vries; Maria Sabater-Lleal; Jennifer E Huffman; Theo K Bammler; Kelly A Frazer; Bryan M McCauley; Kent Taylor; James S Pankow; Alexander P Reiner; Maiken E Gabrielsen; Jean-François Deleuze; Chris J O'Donnell; Jihye Kim; Barbara McKnight; Peter Kraft; John-Bjarne Hansen; Frits R Rosendaal; John A Heit; Bruce M Psaty; Weihong Tang; Charles Kooperberg; Kristian Hveem; Paul M Ridker; Pierre-Emmanuel Morange; Andrew D Johnson; Christopher Kabrhel; David-Alexandre Trégouët; Nicholas L Smith
Journal:  Blood       Date:  2019-11-07       Impact factor: 25.476

3.  Domain-specific mechanical modulation of VWF-ADAMTS13 interaction.

Authors:  Zhenhai Li; Jiangguo Lin; Todd Sulchek; Miguel A Cruz; Jianhua Wu; Jing-Fei Dong; Cheng Zhu
Journal:  Mol Biol Cell       Date:  2019-05-08       Impact factor: 4.138

4.  Genetic and Clinical Predictors of Left Atrial Thrombus: A Single Center Case-Control Study.

Authors:  Adrian Springer; Ruben Schleberger; Florian Oyen; Boris A Hoffmann; Stephan Willems; Christian Meyer; Florian Langer; Renate B Schnabel; Paulus Kirchhof; Reinhard Schneppenheim; Marc D Lemoine
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

5.  Effect of Acute Myocardial Infarction on a Disintegrin and Metalloprotease with Thrombospondin Motif 13 and Von Willebrand Factor and Their Relationship with Markers of Inflammation.

Authors:  Abeer A Al-Masri; Syed Shahid Habib; Ahmad Hersi; Hana Al Zamil
Journal:  Int J Vasc Med       Date:  2020-02-11

6.  Gain-of-Function Variant p.Pro2555Arg of von Willebrand Factor Increases Aggregate Size through Altering Stem Dynamics.

Authors:  Volker Huck; Po-Chia Chen; Emma-Ruoqi Xu; Alexander Tischer; Ulrike Klemm; Camilo Aponte-Santamaría; Christian Mess; Tobias Obser; Fabian Kutzki; Gesa König; Cécile V Denis; Frauke Gräter; Matthias Wilmanns; Matthew Auton; Stefan W Schneider; Reinhard Schneppenheim; Janosch Hennig; Maria A Brehm
Journal:  Thromb Haemost       Date:  2021-04-14       Impact factor: 6.681

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.